SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Auxilium Pharmaceuticals Release: FDA Accepts XIAFLEX® Supplemental Biologics License Application Filing for the Treatment of Peyronie's Disease